Live Virus and Vaccine Manufacturing Challenges
As pharmaceutical and biotechnology companies aim to better their positions within the marketplace, many find themselves outsourcing the production of highly complex products, such as live viruses and vaccines. From the outset, this group of products presents several unique challenges. Simply obtaining the equipment and knowledge needed for successful production requires a considerable investment, often more than a pharmaceutical firm can logically make.